Emicizumab Biosimilar (F9 / Factor IX Reference Antibody)
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
Product Specifications
Target
Emicizumab Biosimilar (Anti-F9 / Factor IX Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
50402064 1.0 µg DNA
WFDC13 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
408411-01 100 mg
1- (Isopropoxycarbonyl) pyrrole-3-boronic acid, pinacol ester
Sign In for Pricing
View Details 408411-02 250 mg
1- (Isopropoxycarbonyl) pyrrole-3-boronic acid, pinacol ester
Sign In for Pricing
View Details